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Temporal arteritis, particularly in its classic form, is exceedingly rare in individuals<50 years old. We report the youngest
case of biopsy-proven giant cell temporal arteritis. A 17-year-old male presented with a progressively expanding and
pulsatile but otherwise asymptomatic mass in his forehead. The patient’s medical history was significant for uveitis since
the age of 3, and severe allergic rhinitis, mild asthma, and juvenile rheumatoid arthritis as a young adolescent. Admission
laboratory values included a mildly elevated erythrocyte sedimentation rate and C-reactive protein level. A computed
tomography evaluation demonstrated aneurysmal degeneration of the frontal branch of the right superficial temporal
artery and confirmed no other cerebrovascular changes. Histologically, the aneurysmal arterial segment demonstrated
subacute temporal arteritis. The arterial wall had a primarily lymphoplasmacytic infiltrate with rare giant cells and focally
marked medial destruction. Additionally, severely obstructive intimal hyperplasia with chronic adventitial and periad-
vential dense fibrosis was noted. The diagnosis of classic giant cell temporal arteritis was established from the biopsy
result. Postoperatively, the patient was treated with prednisone for 3 months. Three years after surgery, the patient
remains well and reports no recurrence of temporal artery disease. ( J Vasc Surg 2006;43:1053-5.)Temporal arteritis is a vasculitis that is extremely rare in
patients 50 years old. In the young, temporal arteritis
exists in two forms: juvenile temporal arteritis and classic
giant cell arteritis. Juvenile temporal arteritis was first re-
ported in the English literature in 1975.1-6 It has a benign
prognosis, and to date, only nine cases have been reported
in the English literature. The classic form is even more
uncommon: only four cases have been reported,7-10 one of
which is disputed.11 We report the youngest case of biopsy-
proven giant cell temporal arteritis.
CASE REPORT
A 17-year-old male was referred to the vascular surgery service
at the University of Nebraska for evaluation of a localized pulsatile
mass in his forehead It was initially noted by the patient 3 months
earlier as a mild, painless swelling, but it had acutely hardened and
expanded over the previous 2 days. The patient denied fever,
malaise, headache, visual changes, or jaw claudication. On exami-
nation, the easily noticeable mass was pulsatile, nontender, oblong,
and located on the frontal belly of the right epicranius muscle. It
started midway between the right eyebrow and the hairline and
extended in serpentine fashion (Fig 1).
The patient’s medical history was significant. Idiopathic uve-
itis had developed at age 3, with a positive antinuclear antibody
(ANA) (1:320). A recent ophthalmology evaluation demonstrated
bilateral aphakia, aphakic glaucoma, and postoperative changes
from a previous corneal transplant with chronic inflammation and
calcium deposits. Severe allergic rhinitis and mild asthma devel-
oped when he was young adolescent. At age 15, juvenile rheuma-
toid arthritis was diagnosed in the right ankle. His medications at
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sulfasalazine, naproxen, and allergy immunotherapy.
Admission laboratory values included an erythrocyte sedimen-
tation rate of 11 mm/h, a C-reactive protein concentration of
3.0 mg/dL, an ANA titer of 1:640, and negative double-stranded
DNA profile. Peripheral blood demonstrated no anemia, a white
cell count of 10,600/L, with 2% eosinophils. Serum electrolytes
were within normal limits.
The patient had normal vital signs, and the rest of his vascular
exam was within normal limits. An ophthalmologic evaluation
showed no new changes and no active ocular vasculitis.
A computed tomography evaluation demonstrated aneurys-
mal degeneration of the frontal branch of the right superficial
temporal artery and confirmed no pathologic changes in the aortic
arch, supra-aortic trunks, or extracranial and intracranial cerebral
vasculature.
The preliminary diagnosis was aneurysmal dilatation of the
frontal branch of the right superficial temporal artery. The patient
was taken to the operating room and under local anesthesia with
intravenous sedation underwent exploration of the diseased artery
and resection of its aneurysmal segment.
Grossly, the arterial segment removed was 1.2 cm long, with
asymmetric aneurysmal dilatation resulting in a diameter that
ranged from 0.4 to 0.7 cm. On cross section, the aneurysmal
portion hadmarked luminal narrowing due to a thickened tan-gray
intima.Microscopically, the resected artery demonstrated subacute
(mildly active and healing) temporal arteritis. The infiltrate in the
artery was composed primarily of lymphocytes and plasma cells and
extended transmurally from intima to adventitia (Figs 2 and 3)
with large areas of internal elastic lamina destruction. Rare,
multinucleated giant cells were present. Eosinophils were not
present.
Marked intimal hyperplasia was present and included large
numbers of smooth muscle cells, as confirmed by immunopheno-
typic marker for smooth muscle actin, and caused severe luminal
stenosis. Luminal thrombus focally contributed to the obstruction.
Medial destruction was focally prominent. Dense adventitial fibro-
sis focally extended into adjacent soft tissue and skeletal muscle and
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active arteritis and presumably represented healing of a previous
inflammatory process.
Postoperatively, the patient was treated with prednisone
Fig 1. Right temporal artery of patient.
Fig 2. Photomicrograph of temporal artery with lymphoplasma-
cytic infiltrate associated with internal elastic lamina and medial
destruction with marked intimal hyperplasia with resultant luminal
obstruction (Masson trichrome 20).(0.5mg/kg daily) in addition to his baseline medications. Thewound healed well, and he was weaned to an alternate-day dosage
of prednisone without any complications. Prednisone was tapered
over 3 months. Three years after surgery, he has remained well and
has reported no recurrence of temporal artery disease.
DISCUSSION
Temporal arteritis is a disease that very rarely affects
persons 50 years of age. In the largest series reported, all
patients were 50 years, and 95% of them were 60
years.12 Age 50 years at disease onset is the first of five
criteria formulated by the American College of Rheumatol-
ogy for the diagnosis of temporal arteritis. The other four
criteria are (1) new onset of localized headache, (2) tem-
poral artery tenderness or decreased temporal artery pulse,
(3) elevated erythrocyte sedimentation rate (Westergren)
50 mm/h, and (4) a biopsy sample that shows necrotiz-
ing arteritis and is characterized by a predominance of
mononuclear cells or granulomas with multinucleated gi-
ant cells.
In the last three decades, 13 patients 40 years old
(range, 7 to 35 years) have been reported with vasculitis of
their temporal arteries. This small group of patients can be
divided into two subgroups by the microscopic features of
their biopsy tissues.
The first form of the disease is characterized by panar-
teritis, occasionally with a prominent eosinophilic infil-
trate4,5 and no granulomas or giant cells. This type of
arteritis was first described in detail by Lie et al1 in 1975 and
was termed juvenile temporal arteritis.2-3 Its original de-
scription may have been as early as 1948, however.13 The
disease has a predilection for young males and presents as a
tender pulsatile mass in the temporal region without any
other accompanying signs or symptoms. On laboratory
evaluation, the erythrocyte sedimentation rate is normal,
Fig 3. Higher power (Masson trichrome 100) photomicro-
graph demonstrates intimal hyperplasia composed of many smooth
muscle cells and scattered lymphocytes with rare giant cells (insert
400).and the peripheral blood often shows hypereosinophilia. A
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tis found an associated activated protein C resistance.6 The
disease has a benign course and requires no corticosteroid
treatment.14
The classic microscopic features of the adult form of
giant cell (temporal) arteritis have only been rarely reported
in younger subjects.6-9 In these few cases, there was a
necrotizing arteritis characterized by a preponderance of
mononuclear cells or granulomas with multinucleated gi-
ant cells. To our knowledge, only five cases, including the
present one, have been reported.6-9 The patients are usually
male and generally describe symptoms lasting several weeks
or months that include localized headache, temporal artery
tenderness, and malaise. Laboratory findings are not con-
sistent. The results of hematologic studies are entirely
normal in some patients, whereas others have leukocytosis
and an elevated erythrocyte sedimentation rate. Treatment
with prednisone has been associated with resolution of
symptoms and absence of recurrences.
The current patient had no systemic complaints,
although his history was complicated by long-standing
ANA-positive uveitis, a recent first-time presentation of
juvenile arthritis, allergic rhinitis, and asthma. Nevertheless,
none of these pre-existing clinical conditions were associ-
ated with temporal arteritis in our literature review. His
significant allergic rhinitis and mild asthma would be ex-
pected to be associated with peripheral blood eosinophilia,
although his peripheral eosinophil count was not elevated.
A microscopic review of temporal artery biopsy tissue pro-
vided a definitive diagnosis and resulted in treatment with
corticosteroids.
Among young adults or adolescents, the literature pro-
vides no distinct differences in the clinical presentation
between temporal arteritis with giant cells and juvenile
temporal arteritis. Our case represents the only reported
patient with a positive ANA and another rheumatologic
condition (uveitis and arthritis). The evaluation of a young
patient with a temporal mass should include a complete
blood count and a sedimentation rate. A total serum im-
munoglobulin E might be of some assistance in patients
with peripheral eosinophilia. Ultimately, the diagnosis is
usually established by microscopic evaluation of temporalartery biopsy tissue. The critical features the pathologist
should describe are the presence or absence of giant cells
and eosinophils. The diagnosis of classic giant cell arteritis
should be considered in all patients (even in those 50
years) presenting with temporal artery related symptoms or
signs.
We appreciate the critical review of Dr James Cassidy,
Child Health, University of Missouri Medical Center.
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